InvestorsHub Logo
icon url

JJM760

07/01/11 12:11 PM

#10119 RE: ronpopeil #10118

There's something in that article that sticks out and is a concern for me as an Ariad investor. this should take BTH all of 5 seconds to figure out.
icon url

bellweather1

07/01/11 12:19 PM

#10121 RE: ronpopeil #10118

Thanks for the article Ron-

Although I realize there is limited space in these blurbs,

I continue to be both amused and encouraged by how so many of these general media biopharma reporters don't even mention 113 as part of Ariad's portfolio-

Yes, I know it's officially pre-clinical, but the prospects are so compelling that it would seem to at least deserve a mention.

This indicates to me that a wide swath of the biopharma world haven't even started to seriously consider it yet, which only portends a positive response when presentations at forums like the WCLC begin to register.

Without getting to smug, I'd have to say we're at least ahead of that curve...
icon url

67stang

07/01/11 7:05 PM

#10129 RE: ronpopeil #10118

So, ARIA is #1 for 52 week overall @ 314%
Impressive...Forbes readers now know about ARIA